(VIANEWS) – Horizon Technology Finance Corporation (HRZN), Radius Health (RDUS), TCG BDC (CGBD) are the highest payout ratio stocks on this list.
We have collected information about stocks with the highest payout ratio so far. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Horizon Technology Finance Corporation (HRZN)
224.56% Payout Ratio
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, cleantech and sustainability industries. It seeks to invest in companies in the United States.
Earnings Per Share
As for profitability, Horizon Technology Finance Corporation has a trailing twelve months EPS of $-0.76.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.76%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 34% and a negative 26.7%, respectively.
Sales Growth
Horizon Technology Finance Corporation’s sales growth is negative 12.5% for the ongoing quarter and negative 7.1% for the next.
2. Radius Health (RDUS)
195.47% Payout Ratio
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Radius Health has a trailing twelve months EPS of $-9.74.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.81%.
Sales Growth
Radius Health’s sales growth is negative 4% for the present quarter and 0.8% for the next.
Yearly Top and Bottom Value
Radius Health’s stock is valued at $18.25 at 20:23 EST, way below its 52-week high of $31.70 and way higher than its 52-week low of $12.69.
3. TCG BDC (CGBD)
95.81% Payout Ratio
Carlyle Secured Lending, Inc. is business development company specializing in first lien debt, senior secured loans, second lien senior secured loan unsecured debt, mezzanine debt and investments in equities. It specializes in directly investing. It specializes in middle market. It targets healthcare and pharmaceutical, aerospace and defense, high tech industries, business services, software, beverage food and tobacco, hotel gamming and leisure, banking finance insurance and in real estate sector. The fund seeks to invest across United States of America, Luxembourg, Cayman Islands, Cyprus, and United Kingdom. It invests in companies with EBITDA between $25 million and $100 million.
Earnings Per Share
As for profitability, TCG BDC has a trailing twelve months EPS of $1.91.
PE Ratio
TCG BDC has a trailing twelve months price to earnings ratio of 9.03. Meaning, the purchaser of the share is investing $9.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.89%.
Moving Average
TCG BDC’s value is higher than its 50-day moving average of $16.90 and above its 200-day moving average of $16.76.
Sales Growth
TCG BDC’s sales growth is negative 4% for the present quarter and negative 8.4% for the next.
Yearly Top and Bottom Value
TCG BDC’s stock is valued at $17.25 at 20:23 EST, under its 52-week high of $18.74 and way higher than its 52-week low of $13.31.
4. Leidos Holdings (LDOS)
47.02% Payout Ratio
Leidos Holdings, Inc. provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. Intelligence Community, Department of Defense, military services, the U.S. Department of Homeland Security, and government agencies of U.S. allies abroad, as well as other federal, civilian, and commercial customers in the national security industry. Its solutions include technology, intelligence systems, command and control platforms, data analytics, logistics, and cybersecurity solutions, as well as intelligence analysis and operations support services to critical missions. The Civil segment provides systems integration services to Air Navigation Service providers, including the Federal Aviation Administration, Transportation Security Administration, and airport operators; and vehicle and cargo inspection system, which enables the scanning of vehicles and cargo that produces an image using a low radiation dose. It also offers information technology (IT) solutions in cloud computing, mobility, application modernization, DevOps, data center, network modernization, asset management, help desk operations, and digital workplace enablement; federal environment and infrastructure; and logistics services. The Health segment offers solutions to federal and commercial customers responsible for health and well-being of people worldwide, including complex systems integration, managed health services, enterprise IT transformation, and life sciences services. Leidos Holdings, Inc. was founded in 1969 and is headquartered in Reston, Virginia.
Earnings Per Share
As for profitability, Leidos Holdings has a trailing twelve months EPS of $3.19.
PE Ratio
Leidos Holdings has a trailing twelve months price to earnings ratio of 51.73. Meaning, the purchaser of the share is investing $51.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.63%.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Volume
Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.
